Jotbody is on the cutting edge of single domain antibody (sdAb, also called nanobody) discovery, production and applications. Jotbody is dedicated to offering sdAb discovery services and sdAb-based research reagents of outstanding quality to the global scientific community.

sdAb is the smallest known antigen binding fragment, leaving an indelible mark on biomedicine. However, its high production cost limits the wide application of sdAb globally. Jotbody, the first biotechnology company to offer shark sdAb discovery in Asia, has demonstrated the use of a common small shark species for the discovery and development of sdAbs at low cost and with easy operation. Jotbody also offers a naïve library for rapid antibody discovery and camelid derived sdAb discovery for therapeutic applications.

So far, we have served several biopharma companies and have earned their strong approval. We have also developed tens of fully-validated sdAb-based research reagents and are liaising with big pharmaceutical companies on product sales.